Purple Biotech Ltd. (PPBT.TA)
ILA 6.9
(-4.17%)
ILA 6.9
(-4.17%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 22.27 Million USD | 99.9% |
| 2022 | -22.6 Million USD | -26.03% |
| 2021 | -17.93 Million USD | -242.2% |
| 2020 | 12.61 Million USD | 276.24% |
| 2019 | -7.15 Million USD | 8.56% |
| 2018 | -7.82 Million USD | 34.42% |
| 2017 | -11.93 Million USD | -66.13% |
| 2016 | -7.18 Million USD | -76.53% |
| 2015 | -4.06 Million USD | 21.46% |
| 2014 | -5.18 Million USD | -102.94% |
| 2013 | -2.55 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -4.46 Million USD | 28.74% |
| 2024 Q2 | -3.45 Million USD | 22.57% |
| 2023 Q4 | -6.26 Million USD | -9.05% |
| 2023 FY | -22.27 Thousand USD | 99.9% |
| 2023 Q1 | -5.12 Million USD | 22.41% |
| 2023 Q2 | 5.13 Million USD | 200.25% |
| 2023 Q3 | -5.74 Million USD | -211.92% |
| 2022 Q3 | -5.08 Million USD | -241.53% |
| 2022 Q4 | -6.6 Million USD | -29.92% |
| 2022 FY | -22.6 Million USD | -26.03% |
| 2022 Q1 | -7.33 Million USD | 33.21% |
| 2022 Q2 | 3.59 Million USD | 148.97% |
| 2021 Q4 | -10.97 Million USD | -443.46% |
| 2021 Q1 | -6.66 Million USD | -40.05% |
| 2021 Q3 | 3.19 Million USD | -11.76% |
| 2021 FY | -17.93 Million USD | -242.2% |
| 2021 Q2 | 3.62 Million USD | 154.33% |
| 2020 Q4 | -4.76 Million USD | -15.17% |
| 2020 Q3 | -4.13 Million USD | -92.17% |
| 2020 Q2 | -2.15 Million USD | 0.0% |
| 2020 Q1 | -2.15 Million USD | -89.77% |
| 2020 FY | 12.61 Million USD | 276.24% |
| 2019 Q4 | -1.13 Million USD | 29.97% |
| 2019 Q2 | -1.78 Million USD | 0.0% |
| 2019 Q1 | -1.78 Million USD | -27.52% |
| 2019 FY | -7.15 Million USD | 8.56% |
| 2019 Q3 | -1.61 Million USD | 9.15% |
| 2018 Q4 | -1.39 Million USD | 0.0% |
| 2018 FY | -7.82 Million USD | 34.42% |
| 2018 Q3 | -1.39 Million USD | 46.64% |
| 2018 Q2 | -2.61 Million USD | 0.0% |
| 2018 Q1 | -2.61 Million USD | -4.03% |
| 2017 Q3 | -2.51 Million USD | 0.14% |
| 2017 FY | -11.93 Million USD | -66.13% |
| 2017 Q4 | -2.51 Million USD | 0.0% |
| 2017 Q1 | -2.52 Million USD | -27.89% |
| 2017 Q2 | -2.52 Million USD | 0.0% |
| 2016 Q2 | -1.57 Million USD | 0.0% |
| 2016 Q4 | -1.97 Million USD | 0.0% |
| 2016 FY | -7.18 Million USD | -76.53% |
| 2016 Q1 | -1.57 Million USD | -26.42% |
| 2016 Q3 | -1.97 Million USD | -24.79% |
| 2015 FY | -4.06 Million USD | 21.46% |
| 2015 Q4 | -1.24 Million USD | -4.69% |
| 2015 Q3 | -1.19 Million USD | -20.26% |
| 2015 Q2 | -992 Thousand USD | -56.22% |
| 2015 Q1 | -635 Thousand USD | 27.35% |
| 2014 Q3 | -1.18 Million USD | 33.61% |
| 2014 Q4 | -874 Thousand USD | 26.12% |
| 2014 Q2 | -1.78 Million USD | -186.5% |
| 2014 FY | -5.18 Million USD | -102.94% |
| 2014 Q1 | -622 Thousand USD | -133.83% |
| 2013 Q2 | -213 Thousand USD | -85.22% |
| 2013 FY | -2.55 Million USD | 0.0% |
| 2013 Q4 | -266 Thousand USD | 53.82% |
| 2013 Q3 | -576 Thousand USD | -170.42% |
| 2013 Q1 | -115 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Matricelf Ltd | -12.59 Million ILA | 276.81% |